Literature DB >> 8582789

Morphine affects cytostatic activity of macrophages by the modulation of nitric oxide release.

R Pacifici1, M Minetti, P Zuccaro, D Pietraforte.   

Abstract

The serum levels of morphine and its glucuronide metabolites were quantitated in C57BL/6 mice at various intervals following subcutaneous administration of morphine. Since one of the major mechanisms of killing by macrophages is the production of nitric oxide, pharmacokinetics data were correlated with cytostatic activity and the release of NO2- (stable end product of NO metabolism). Morphine and its 3-glucuronide metabolite appear in serum of treated mice, reaching a peak of concentration at 20 min. However, morphine 3'-glucuronide levels were much higher than those of the drug itself, even when the morphine concentration levelled off. Both cytostasis and NO2- production of L1210-activated macrophages were significantly enhanced by opioid treatment immediately after drug injection (peaking after 40 min). In contrast, morphine induced a strong inhibition of both cytostasis and NO2- production 24 h after treatment. The modulation of both cytostasis and NO2- production induced by morphine was completely antagonized by pretreatment of mice with the opioid antagonist naltrexone. The involvement of an inducible isoform of NO synthase was suggested by the inhibitory effects of dexamethasone on NO2- production. These data indicate that in vivo administration of morphine can induce a modulation of the NO biosynthesis of peritoneal macrophages.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8582789     DOI: 10.1016/0192-0561(95)00046-5

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  9 in total

Review 1.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

Review 2.  Interactions between morphine and nitric oxide in various organs.

Authors:  Noboru Toda; Shiroh Kishioka; Yoshio Hatano; Hiroshi Toda
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

3.  Effect of morphine on Mycobacterium smegmatis infection in mice and macrophages.

Authors:  Raman Preet Singh; Sarbjit Singh Jhamb; Prati Pal Singh
Journal:  Indian J Microbiol       Date:  2009-08-20       Impact factor: 2.461

4.  Augmented production of proinflammatory cytokines and accelerated allotransplantation reactions in heroin-treated mice.

Authors:  V Holán; A Zajícová; M Krulova; V Blahoutová; H Wilczek
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

5.  A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit.

Authors:  Geraldine De Muylder; Kenny K H Ang; Steven Chen; Michelle R Arkin; Juan C Engel; James H McKerrow
Journal:  PLoS Negl Trop Dis       Date:  2011-07-19

Review 6.  Expression of Opioid Receptors in Cells of the Immune System.

Authors:  Jana Brejchova; Vladimir Holan; Petr Svoboda
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

Review 7.  Opioids Regulate the Immune System: Focusing on Macrophages and Their Organelles.

Authors:  Shaohua Wen; Yuan Jiang; Shuang Liang; Zhigang Cheng; Xiaoyan Zhu; Qulian Guo
Journal:  Front Pharmacol       Date:  2022-01-12       Impact factor: 5.810

8.  Morphine-induced neuroimmunomodulation in murine visceral leishmaniasis: the role(s) of cytokines and nitric oxide.

Authors:  Prati Pal Singh; Priya Singal
Journal:  J Neuroimmune Pharmacol       Date:  2007-10-10       Impact factor: 7.285

9.  Evaluation of Morphine with Imiquimod as Opioid Growth Factor Receptor or Nalmefene as Opioid Blocking Drug on Leishmaniasis Caused by Leishmania major in Vitro.

Authors:  Javad Jabari; Fatemeh Ghaffarifar; John Horton; Abdolhosein Dalimi; Zohreh Sharifi
Journal:  Iran J Parasitol       Date:  2019 Jul-Sep       Impact factor: 1.012

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.